See the DrugPatentWatch profile for cosentyx

Based on the information available, it is not recommended to lower the dose of Cosentyx without consulting a healthcare professional. Cosentyx, also known as secukinumab, is a prescription medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. The safety and efficacy of Cosentyx are based on specific dosages determined by a physician, considering the patient's medical history, current health status, and other factors [1].

Altering the dosage without medical advice can lead to suboptimal treatment outcomes or potential adverse effects [1]. It is essential to consult a healthcare professional before making any changes to a medication regimen, as they can provide personalized guidance based on a comprehensive understanding of the patient's health [1].

In summary, lowering the dose of Cosentyx without consulting a doctor is not advised, as it may compromise the treatment's safety and efficacy. Always consult a healthcare professional for personalized advice regarding medication dosages.

Sources:
[1] DrugPatentWatch.com. (n.d.). Cosentyx (secukinumab) - DrugPatentWatch. Retrieved from https://www.drugpatentwatch.com/cosentyx-secukinumab/